AA
TIL icon

ALPS Advisors’s Instil Bio TIL Stock Holding History

ALPS Advisors’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,541
Closed -$343K – 1085
2022
Q3 		$343K Sell
3,541
-294
-8% -$33.6K ﹤0.01% 677
2022
Q2 		$354K Sell
3,835
-2,801
-42% -$397K ﹤0.01% 690
2022
Q1 		$1.43M Sell
6,636
-824
-11% -$193K 0.02% 278
2021
Q4 		$2.55M Buy
+7,460
New +$2.88M 0.03% 230

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ALPS Advisors's TIL Position: Q4 2022 in Review

ALPS Advisors sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 3,541 shares — an estimated $343K sold.

ALPS Advisors first reported a position in TIL in Q4 2021 and held it in 4 quarters. The position peaked at $2.55M in Q4 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • ALPS Advisors reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • ALPS Advisors sold 3,541 Instil Bio shares in Q4 2022, an estimated $343K.
  • ALPS Advisors first reported a position in Instil Bio in Q4 2021 and held it in 4 quarters.
  • ALPS Advisors's Instil Bio position peaked at $2.55M in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.